Ruminiclostridium 9 has also been shown to regulate lipid metabolism, reduces inflammation, enhances intestinal barrier function, and increases insulin sensitivity, thereby potentially reducing the development of obesity—a known risk factor for pancreatic cancer. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.